Neurological complications of sarcoidosis

Research output: Contribution to journalReview article

Abstract

Purpose of review: The neurological manifestations of sarcoidosis, which occur in 5% of patients with the condition, present in a variety of ways that can be assigned to several broad categories. A comprehensive approach to the diagnosis and management of neurosarcoidosis involves an appreciation of the strategies to confirm a diagnosis of sarcoidosis and neurosarcoidosis and the available therapeutic options. Recent findings: In addition to traditional approaches to the diagnosis of sarcoidosis, positron emission tomography can be used to identify otherwise occult sites of systemic inflammation which can be targeted for biopsy. Although corticosteroids remain the mainstay of treatment, other immunosuppressive and immunomodulatory agents can be used in the multi-modality therapy of sarcoidosis. Summary: Neurosarcoidosis can be 'staged' with the use of neurodiagnostic testing and diagnosed with varying degrees of certainty. Treatment should be approached within the context of the anticipated clinical course of the patient, avoidance of adverse drug effects, and, as necessary, from the perspective of the comprehensive management of a chronic disease.

Original languageEnglish (US)
Pages (from-to)311-316
Number of pages6
JournalCurrent Opinion in Neurology
Volume17
Issue number3
DOIs
StatePublished - Jun 1 2004
Externally publishedYes

Fingerprint

Sarcoidosis
Therapeutics
Immunosuppressive Agents
Neurologic Manifestations
Positron-Emission Tomography
Adrenal Cortex Hormones
Chronic Disease
Inflammation
Biopsy
Pharmaceutical Preparations
Neurosarcoidosis

Keywords

  • Immunomodulation
  • Immunosuppression
  • Neurosarcoidosis
  • Sarcoidosis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Neurological complications of sarcoidosis. / Stern, Barney.

In: Current Opinion in Neurology, Vol. 17, No. 3, 01.06.2004, p. 311-316.

Research output: Contribution to journalReview article

@article{ec24a6471d054411a5d30d033eeaa67f,
title = "Neurological complications of sarcoidosis",
abstract = "Purpose of review: The neurological manifestations of sarcoidosis, which occur in 5{\%} of patients with the condition, present in a variety of ways that can be assigned to several broad categories. A comprehensive approach to the diagnosis and management of neurosarcoidosis involves an appreciation of the strategies to confirm a diagnosis of sarcoidosis and neurosarcoidosis and the available therapeutic options. Recent findings: In addition to traditional approaches to the diagnosis of sarcoidosis, positron emission tomography can be used to identify otherwise occult sites of systemic inflammation which can be targeted for biopsy. Although corticosteroids remain the mainstay of treatment, other immunosuppressive and immunomodulatory agents can be used in the multi-modality therapy of sarcoidosis. Summary: Neurosarcoidosis can be 'staged' with the use of neurodiagnostic testing and diagnosed with varying degrees of certainty. Treatment should be approached within the context of the anticipated clinical course of the patient, avoidance of adverse drug effects, and, as necessary, from the perspective of the comprehensive management of a chronic disease.",
keywords = "Immunomodulation, Immunosuppression, Neurosarcoidosis, Sarcoidosis",
author = "Barney Stern",
year = "2004",
month = "6",
day = "1",
doi = "10.1097/00019052-200406000-00013",
language = "English (US)",
volume = "17",
pages = "311--316",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Neurological complications of sarcoidosis

AU - Stern, Barney

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Purpose of review: The neurological manifestations of sarcoidosis, which occur in 5% of patients with the condition, present in a variety of ways that can be assigned to several broad categories. A comprehensive approach to the diagnosis and management of neurosarcoidosis involves an appreciation of the strategies to confirm a diagnosis of sarcoidosis and neurosarcoidosis and the available therapeutic options. Recent findings: In addition to traditional approaches to the diagnosis of sarcoidosis, positron emission tomography can be used to identify otherwise occult sites of systemic inflammation which can be targeted for biopsy. Although corticosteroids remain the mainstay of treatment, other immunosuppressive and immunomodulatory agents can be used in the multi-modality therapy of sarcoidosis. Summary: Neurosarcoidosis can be 'staged' with the use of neurodiagnostic testing and diagnosed with varying degrees of certainty. Treatment should be approached within the context of the anticipated clinical course of the patient, avoidance of adverse drug effects, and, as necessary, from the perspective of the comprehensive management of a chronic disease.

AB - Purpose of review: The neurological manifestations of sarcoidosis, which occur in 5% of patients with the condition, present in a variety of ways that can be assigned to several broad categories. A comprehensive approach to the diagnosis and management of neurosarcoidosis involves an appreciation of the strategies to confirm a diagnosis of sarcoidosis and neurosarcoidosis and the available therapeutic options. Recent findings: In addition to traditional approaches to the diagnosis of sarcoidosis, positron emission tomography can be used to identify otherwise occult sites of systemic inflammation which can be targeted for biopsy. Although corticosteroids remain the mainstay of treatment, other immunosuppressive and immunomodulatory agents can be used in the multi-modality therapy of sarcoidosis. Summary: Neurosarcoidosis can be 'staged' with the use of neurodiagnostic testing and diagnosed with varying degrees of certainty. Treatment should be approached within the context of the anticipated clinical course of the patient, avoidance of adverse drug effects, and, as necessary, from the perspective of the comprehensive management of a chronic disease.

KW - Immunomodulation

KW - Immunosuppression

KW - Neurosarcoidosis

KW - Sarcoidosis

UR - http://www.scopus.com/inward/record.url?scp=2642535993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2642535993&partnerID=8YFLogxK

U2 - 10.1097/00019052-200406000-00013

DO - 10.1097/00019052-200406000-00013

M3 - Review article

VL - 17

SP - 311

EP - 316

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 3

ER -